Alturos Therapeutics

Alturos Therapeutics is advancing a pipeline of first-in-class, neuroprotective small molecules designed to decouple toxic protein aggregation from neuronal death. While current therapies focus on clearing existing plaques, our lead program disrupts the pathological signaling driven by two key triggers of Alzheimer's disease: amyloid-beta and tau oligomers.